191 related articles for article (PubMed ID: 24501708)
1. Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy.
Jeong S; Yoo EJ; Kim JY; Han CW; Kim KJ; Kay CS
Radiat Oncol J; 2013 Dec; 31(4):206-15. PubMed ID: 24501708
[TBL] [Abstract][Full Text] [Related]
2. Reirradiation with IMRT for recurrent head and neck cancer: A single-institutional report on disease control, survival, and toxicity.
Ahlawat P; Rawat S; Kakria A; Devnani B; Wahi IK; Simson DK
Rep Pract Oncol Radiother; 2017; 22(4):331-339. PubMed ID: 28663716
[TBL] [Abstract][Full Text] [Related]
3. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
4. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
[TBL] [Abstract][Full Text] [Related]
5. High-Dose Thoracic Re-irradiation of Lung Cancer Using Highly Conformal Radiotherapy Is Effective with Acceptable Toxicity.
Hong JH; Kim YS; Lee SW; Lee SJ; Kang JH; Hong SH; Hong JY; Cheon G
Cancer Res Treat; 2019 Jul; 51(3):1156-1166. PubMed ID: 30514067
[TBL] [Abstract][Full Text] [Related]
6. Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Santa Cruz O; Tsoutsou P; Castella C; Khanfir K; Anchisi S; Bouayed S; Matzinger O; Ozsahin M
Oncology; 2018; 95(2):61-68. PubMed ID: 29895020
[TBL] [Abstract][Full Text] [Related]
7. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
8. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
Megahed R; Prabhu AV; Mack DP; Gholami S; Samanta S; Patel M; Lewis GD
Oral Oncol; 2024 May; 152():106778. PubMed ID: 38555751
[TBL] [Abstract][Full Text] [Related]
9. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
[TBL] [Abstract][Full Text] [Related]
10. Comparison of survival rates between patients treated with conventional radiotherapy and helical tomotherapy for head and neck cancer.
Kong M; Hong SE; Choi J; Kim Y
Radiat Oncol J; 2013 Mar; 31(1):1-11. PubMed ID: 23620863
[TBL] [Abstract][Full Text] [Related]
11. Results of radiotherapy in squamous cell laryngeal cancer: A tomotherapy center experience.
Bolukbas MK; Turna M; Karaca S; Basaran H
Indian J Cancer; 2022; 59(3):330-336. PubMed ID: 33402605
[TBL] [Abstract][Full Text] [Related]
12. Re-irradiation for head and neck cancer: outcome and toxicity analysis using a prospective single institution database.
Scolari C; Buchali A; Franzen A; Förster R; Windisch P; Bodis S; Zwahlen DR; Schröder C
Front Oncol; 2023; 13():1175609. PubMed ID: 37456239
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation for recurrent or second primary head and neck cancer.
Lee HI; Kim JH; Ahn SH; Chung EJ; Keam B; Eom KY; Jeong WJ; Kim JW; Wee CW; Wu HG
Radiat Oncol J; 2021 Dec; 39(4):279-287. PubMed ID: 34986549
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy.
Hagiwara Y; Yamada S; Isozaki Y; Takiyama H; Shinoto M; Kawashiro S; Bhattacharyya T; Nemoto K; Tsuji H
Clin Transl Radiat Oncol; 2021 Jan; 26():24-29. PubMed ID: 33294643
[TBL] [Abstract][Full Text] [Related]
16. Proton re-irradiation of unresectable recurrent head and neck cancers.
Gordon K; Gulidov I; Semenov A; Golovanova O; Koryakin S; Makeenkova T; Ivanov S; Kaprin A
Rep Pract Oncol Radiother; 2021; 26(2):203-210. PubMed ID: 34211770
[TBL] [Abstract][Full Text] [Related]
17. Salvage re-irradiation for recurrent head and neck cancer.
Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
[TBL] [Abstract][Full Text] [Related]
18. The potential of helical tomotherapy in the treatment of head and neck cancer.
Van Gestel D; Verellen D; Van De Voorde L; de Ost B; De Kerf G; Vanderveken O; Van Laer C; Van den Weyngaert D; Vermorken JB; Gregoire V
Oncologist; 2013 Jun; 18(6):697-706. PubMed ID: 23723331
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
20. Conformal re-irradiation of recurrent and new primary head-and-neck cancer.
Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
